Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

Figure 4

Prognostic value of RRM2 in ER-negative breast cancers. For the public breast cancer microarray data, we pooled all eligible breast cancers after normalizing. We performed Kaplan-Meier analysis of RRM2 for the OS (A) and PFS (B) of breast cancer patients. Cox proportional analysis results are shown for OS and PFS in (C) and (D). Findings were verified in the ZJU set. The prognostic performance of RRM2 for ER-negative and ER-positive breast cancers is shown in (E) and (F), respectively.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us